Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Nuclear Cardiology
Published in: Journal of Nuclear Cardiology 4/2015

01-08-2015 | Review Article

Review of cardiovascular imaging in The Journal of Nuclear Cardiology in 2014: Part 2 of 2: Myocardial perfusion imaging

Authors: Fadi G. Hage, MD, FASH, FACC, Wael A. AlJaroudi, MD, FACC, FAHA, FESC

Published in: Journal of Nuclear Cardiology | Issue 4/2015

Login to get access

Abstract

In this new feature of The Journal of Nuclear Cardiology we will summarize key articles that were published in the Journal in the previous year. In the first article of this 2-part series we concentrated on publications dealing with cardiac positron emission tomography, computed tomography, and neuronal imaging. This review will focus on myocardial perfusion imaging summarizing advances in the field including in diagnosis, prognosis, appropriateness, and safety of testing.
Literature
1.
Shaw LJ, Hage FG, Berman DS, Hachamovitch R, Iskandrian A. Prognosis in the era of comparative effectiveness research: where is nuclear cardiology now and where should it be? J Nucl Cardiol. 2012;19:1026-43.CrossRefPubMed
2.
Katsikis A, Theodorakos A, Papaioannou S, Tsapaki V, Kolovou G, Drosatos A, et al. Long-term prognostic value of myocardial perfusion imaging in octogenarians able to undergo treadmill exercise stress testing. J Nucl Cardiol. 2014;21:1213-22.CrossRefPubMed
3.
Rozanski A, Gransar H, Min JK, Hayes SW, Friedman JD, Thomson LE, et al. Long-term mortality following normal exercise myocardial perfusion SPECT according to coronary disease risk factors. J Nucl Cardiol. 2014;21:341-50.CrossRefPubMed
4.
Acampa W, Petretta M, Cuocolo R, Daniele S, Cantoni V, Cuocolo A. Warranty period of normal stress myocardial perfusion imaging in diabetic patients: a propensity score analysis. J Nucl Cardiol. 2014;21:50-6.CrossRefPubMed
5.
Acampa W, Cantoni V, Green R, Maio F, Daniele S, Nappi C, et al. Prognostic value of normal stress myocardial perfusion imaging in diabetic patients: a meta-analysis. J Nucl Cardiol. 2014;21:893-902, quiz 890-2, 903-5.CrossRefPubMed
6.
Padala SK, Ghatak A, Padala S, Katten DM, Polk DM, Heller GV. Cardiovascular risk stratification in diabetic patients following stress single-photon emission-computed tomography myocardial perfusion imaging: the impact of achieved exercise level. J Nucl Cardiol. 2014;21:1132-43.CrossRefPubMed
7.
Chen J, Garcia EV, Bax JJ, Iskandrian AE, Borges-Neto S, Soman P. SPECT myocardial perfusion imaging for the assessment of left ventricular mechanical dyssynchrony. J Nucl Cardiol. 2011;18:685-94.PubMedCentralCrossRefPubMed
8.
Salimian S, Thibault B, Finnerty V, Gregoire J, Harel F. The effects of dobutamine stress on cardiac mechanical synchrony determined by phase analysis of gated SPECT myocardial perfusion imaging in a canine model. J Nucl Cardiol. 2014;21:375-83.CrossRefPubMed
9.
Zafrir N, Nevzorov R, Bental T, Strasberg B, Gutstein A, Mats I, et al. Prognostic value of left ventricular dyssynchrony by myocardial perfusion-gated SPECT in patients with normal and abnormal left ventricular functions. J Nucl Cardiol. 2014;21:532-40.CrossRefPubMed
10.
Hage FG, Aggarwal H, Patel K, Chen J, Jacobson AF, Heo J, et al. The relationship of left ventricular mechanical dyssynchrony and cardiac sympathetic denervation to potential sudden cardiac death events in systolic heart failure. J Nucl Cardiol. 2014;21:78-85.CrossRefPubMed
11.
Goldberg AS, Alraies MC, Cerqueira MD, Jaber WA, Aljaroudi WA. Prognostic value of left ventricular mechanical dyssynchrony by phase analysis in patients with non-ischemic cardiomyopathy with ejection fraction 35-50% and QRS < 150 ms. J Nucl Cardiol. 2014;21:57-66.CrossRefPubMed
12.
Aggarwal H, AlJaroudi WA, Mehta S, Mannon R, Heo J, Iskandrian AE, et al. The prognostic value of left ventricular mechanical dyssynchrony using gated myocardial perfusion imaging in patients with end-stage renal disease. J Nucl Cardiol. 2014;21:739-46.CrossRefPubMed
13.
Huang WS, Huang CH, Lee CL, Chen CP, Hung GU, Chen J. Relation of early post-stress left ventricular dyssynchrony and the extent of angiographic coronary artery disease. J Nucl Cardiol. 2014;21:1048-56.CrossRefPubMed
14.
Zhang H, Hou X, Wang Y, Xue S, Cao K, Chen J, et al. The acute and chronic effects of different right ventricular site pacing on left ventricular mechanical synchrony as assessed by phase analysis of SPECT myocardial perfusion imaging. J Nucl Cardiol. 2014;21:958-66.CrossRefPubMed
15.
Patil HR, Bateman TM, McGhie AI, Burgett EV, Courter SA, Case JA, et al. Diagnostic accuracy of high-resolution attenuation-corrected Anger-camera SPECT in the detection of coronary artery disease. J Nucl Cardiol. 2014;21:127-34.CrossRefPubMed
16.
Mut F, Giubbini R, Vitola J, Lusa L, Sobic-Saranovic D, Peix A, et al. Detection of post-exercise stunning by early gated SPECT myocardial perfusion imaging: results from the IAEA multi-center study. J Nucl Cardiol. 2014;21:1168-76.CrossRefPubMed
17.
Nudi F, Pinto A, Procaccini E, Neri G, Vetere M, Tomai F, et al. A novel clinically relevant segmentation method and corresponding maximal ischemia score to risk-stratify patients undergoing myocardial perfusion scintigraphy. J Nucl Cardiol. 2014;21:807-18.CrossRefPubMed
18.
Fransson H, Ljungberg M, Carlsson M, Engblom H, Arheden H, Heiberg E. Validation of an automated method to quantify stress-induced ischemia and infarction in rest-stress myocardial perfusion SPECT. J Nucl Cardiol. 2014;21:503-18.CrossRefPubMed
19.
Takamine S, Fujiwara S, Shigeru M, Ito T, Kawai H, Shiotani H, et al. Relationship of decreased accumulation of (99m)Tc-tetrofosmin on myocardial single-photon emission computed tomography images between QRS duration in dilated cardiomyopathy patient with left bundle branch block. J Nucl Cardiol. 2014;21:1023-8.CrossRefPubMed
20.
Mouden M, Ottervanger JP, Timmer JR, Reiffers S, Oostdijk AH, Knollema S, et al. The influence of coronary calcium score on the interpretation of myocardial perfusion imaging. J Nucl Cardiol. 2014;21:368-74.CrossRefPubMed
21.
Ather S, Iqbal F, Gulotta J, Aljaroudi W, Heo J, Iskandrian AE, et al. Comparison of three commercially available softwares for measuring left ventricular perfusion and function by gated SPECT myocardial perfusion imaging. J Nucl Cardiol. 2014;21:673-81.CrossRefPubMed
22.
Ronan G, Wolk MJ, Bailey SR, Doherty JU, Douglas PS, Hendel RC, et al. ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. J Nucl Cardiol. 2014;21:192-220.CrossRefPubMed
23.
Winchester DE, Hymas J, Meral R, Nguyen D, Dusaj R, Shaw LJ, et al. Clinician-dependent variations in inappropriate use of myocardial perfusion imaging: training, specialty, and location. J Nucl Cardiol. 2014;21:598-604.CrossRefPubMed
24.
Yokota S, Ottervanger JP, Mouden M, Timmer JR, Knollema S, Jager PL. Prevalence, location, and extent of significant coronary artery disease in patients with normal myocardial perfusion imaging. J Nucl Cardiol. 2014;21:284-90.CrossRefPubMed
25.
Hsi DH, Marreddy R, Moshiyakhov M, Luft U. Regadenoson induced acute ST-segment elevation myocardial infarction and multivessel coronary thrombosis. J Nucl Cardiol. 2013;20:481-4.CrossRefPubMed
26.
Shah S, Parra D, Rosenstein RS. Acute myocardial infarction during regadenoson myocardial perfusion imaging. Pharmacotherapy. 2013;33:e90-5.CrossRefPubMed
27.
Rosenblatt J, Mooney D, Dunn T, Cohen M. Asystole following regadenoson infusion in stable outpatients. J Nucl Cardiol. 2014;21:862-8.CrossRefPubMed
28.
Agarwal V, DePuey EG. Regadenoson and seizures: a real clinical concern. J Nucl Cardiol. 2014;21:869-70.CrossRefPubMed
29.
30.
Hage FG, Iskandrian AE. Serious complications associated with regadenoson administration for myocardial perfusion imaging: a commentary. J Nucl Cardiol. 2014;21:877-9.CrossRefPubMed
Metadata
Title
Review of cardiovascular imaging in The Journal of Nuclear Cardiology in 2014: Part 2 of 2: Myocardial perfusion imaging
Authors
Fadi G. Hage, MD, FASH, FACC
Wael A. AlJaroudi, MD, FACC, FAHA, FESC
Publication date
01-08-2015
Publisher
Springer US
Published in
Journal of Nuclear Cardiology / Issue 4/2015
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-015-0144-1

Other articles of this Issue 4/2015

Journal of Nuclear Cardiology 4/2015 Go to the issue

Images that Teach

99mTc-HMDP scintigraphy rectifies wrong diagnosis of AL amyloidosis

Training Statement

COCATS 4 Task Force 7: Training in Cardiovascular Computed Tomographic Imaging

Editorial

FDG PET/CT in cardiac electronic devices infection: Now is the time to target guidelines implementation

Editorial

Application of inverse probability weights in survival analysis

Editorial

Imaging in patients with advanced therapies for heart failure

Erratum

Erratum to: CME instructions: Cardiac imaging for the assessment of patients being evaluated for kidney or liver transplantation

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits